Kancera AB (publ) announced that Peter Selin has been appointed as Executive Vice President Corporate Development, responsible for business development, strategic partnerships and licensings. He will be part of the management team and report directly to the CEO. Peter Selin is joining from Oasmia Pharmaceutical and the position as Chief Business Officer. Peter has previously held various senior business development and operational positions, including as Vice President Business Operations at Inceptua Group and Vice President Corporate Development at Sobi. Peter Selin will take up his position as soon as practically possible but at the latest on May 1, 2022.